Chronic Myeloproliferative Disorders

ISBN-13: 9780415415989 / Angielski / Twarda / 2008 / 256 str.

Tariq Mughal;John Goldman

Opis

With the new classification of chronic myeloproliferative disorders, and the rise of interest in molecularly targeted therapies, it is timely to bring together the international experts on the topic to discuss the state of the art and the implications for the treatment of patients. This well illustrated text will be an essential resource for all practitioners in Hematologic Oncology.

Spis treści

I. Bcr/Abl Positive Chronic Myeloproliferative Disorders. 1. Epidemiology and history. 2. Cytogenetics and molecular biology. 3. Risk stratification. 4. Clinical features. 5. Non-transplant treatment options. 6. Allogeneic stem cell transplantation. 7. Autologous stem cell transplantation. 8. Vaccines. 9. A therapeutic algorithm and concluding remarks. II. Bcr/Abl Negative Chronic Myeloproliferative Disorders. 10. Epidemiology and history. 11. Cytogenetics and molecular biology. 12. Risk stratification. 13. Clinical features. 14. Non-transplant treatment options. 15. Transplantation options. 16. A therapeutic algorithm and concluding remarks.